Consolidated Planning Corp Decreases Position in UnitedHealth Group Incorporated (NYSE:UNH)

Consolidated Planning Corp lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 30.3% in the first quarter, HoldingsChannel reports. The firm owned 1,365 shares of the healthcare conglomerate’s stock after selling 594 shares during the period. Consolidated Planning Corp’s holdings in UnitedHealth Group were worth $715,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of UNH. NewSquare Capital LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $26,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $28,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $30,000. Finally, Promus Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at approximately $32,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UNH opened at $302.04 on Monday. The firm has a market cap of $273.99 billion, a PE ratio of 12.65, a P/E/G ratio of 1.42 and a beta of 0.45. The business has a fifty day simple moving average of $359.15 and a 200-day simple moving average of $461.96. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same period last year, the business earned $6.91 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.93%. The ex-dividend date of this dividend is Monday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio (DPR) is 37.02%.

Insider Buying and Selling

In other news, CFO John F. Rex acquired 17,175 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The stock was acquired at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the acquisition, the chief financial officer now owns 203,796 shares in the company, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director John H. Noseworthy acquired 300 shares of the business’s stock in a transaction that occurred on Wednesday, May 14th. The shares were purchased at an average price of $312.16 per share, with a total value of $93,648.00. Following the completion of the acquisition, the director now owns 6,063 shares of the company’s stock, valued at $1,892,626.08. This represents a 5.21% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.28% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on UNH shares. Bank of America cut UnitedHealth Group from a “buy” rating to a “neutral” rating and lowered their target price for the company from $560.00 to $350.00 in a research report on Wednesday, May 14th. Mizuho lowered their target price on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research report on Friday, May 16th. TD Securities restated a “hold” rating and issued a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Robert W. Baird cut UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 target price on the stock. in a research report on Wednesday, June 11th. Finally, Oppenheimer decreased their price target on UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a research note on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $427.09.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.